Alerts will be sent to your verified email
Verify Email
SUDARSHAN
|
Sudarshan Pharma Ind
|
Ind-Swift Lab.
|
Shree Ganesh Remed.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.77 % | 9.6 % | 20.54 % |
|
5yr Avg Net Profit Margin
|
2.0 % | 6.7 % | 19.4 % |
|
Price to Book
|
6.0 | 0.68 | 5.22 |
|
P/E
|
49.43 | 3.44 | 34.62 |
|
5yr Avg Cash Conversion Cycle
|
121.83 Days | 76.78 Days | 74.82 Days |
|
5yr Average Interest Coverage Ratio
|
2.61 | 3.49 | 37.3 |
|
5yr Avg ROCE
|
23.07 % | 12.63 % | 25.4 % |
|
5yr Avg Operating Profit Margin
|
4.55 % | 19.31 % | 28.41 % |
|
5 yr average Debt to Equity
|
0.99 | 1.22 | 0.17 |
|
5yr CAGR Net Profit
|
42.99 % | n/a | 29.89 % |
|
5yr Average Return on Assets
|
3.51 % | 7.66 % | 15.33 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.39 % | 40.94 % | 72.8 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-31.89 % | -1.06 % | 3.68 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sudarshan Pharma Ind
|
Ind-Swift Lab.
|
Shree Ganesh Remed.
|
|---|